标普和纳斯达克内在价值 联系我们

Cytek Biosciences, Inc. CTKB NASDAQ

NASDAQ Global Select • Healthcare • Medical - Devices • US • USD

SharesGrow Score
50/100
2/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$6.00
+27.9%

Cytek Biosciences, Inc. (CTKB) has 18 已知的内部人和机构持有人记录. 最大持有人为 Shah Rajeev M. 持有 13,381,054 股. 其他重要持有人包括 RA CAPITAL MANAGEMENT, L.P. 和 Yan Ming.

过去12个月,内部人进行了 32 笔交易,涉及 CTKB 股票 — 8 笔买入 (价值为 $509.59K) 和 0 笔卖出 (价值为 RSU 奖励). 内部人买入超过卖出,可能表明对公司前景有信心.

CTKB 內部人持股

最大持股人
Shah Rajeev M.
13,381,054 股
买入(12个月)
8
$509.59K 价值
卖出(12个月)
0
$0.00 价值
12个月交易活动
买入 25%
卖出 0%
主要內部人持股
# 姓名 职位 持股数量 最近申报日期 相对规模
1 Shah Rajeev M. Director 13,381,054 2022-03-16
100%
2 Ra Capital Management, L.p. 10 Percent Owner 13,139,327 2022-03-16
98%
3 Yan Ming Chief Technology Officer 4,915,933 2026-03-13
37%
4 Mccombe William D. Chief Financial Officer 56,889 2026-03-12
0%
5 Jiang Wenbin President and CEO 47,129 2026-03-12
0%
6 Jeanmonod Patrik Chief Financial Officer 44,182 2024-03-13
0%
7 Dion Gisele Director 30,242 2023-06-16
0%
8 Ball Jack Director 23,809 2025-06-20
0%
9 Imper Vera Director 23,809 2025-06-20
0%
10 Neff Deborah J Director 23,809 2025-06-20
0%
11 Chin Richard Director 16,285 2026-03-12
0%
12 Hardison Don M Director 15,706 2024-06-07
0%
13 Barnett Valerie Chief Legal Officer 14,734 2026-03-12
0%
14 Holder Michael Director 10,911 2026-03-12
0%
15 Williams Paul Christopher Chief Operating Officer 9,063 2024-08-21
0%
16 Garland Jonathan Todd Chief Commercial Officer 7,078 2023-08-21
0%
17 Busque Philippe SVP, Global Sales and Services 6,665 2026-03-12
0%
18 Poirson Allen SVP Bus. and Corp. Dev. 3,693 2024-11-20
0%
近期交易 (过去12个月)
日期 姓名 职位 类型 股数 股价 总价值
2026-03-13 Yan Ming Chief Technology Officer 赠与(送出) 1,176,000 - -
2026-03-10 Busque Philippe SVP, Global Sales and Services 期权行权(卖出) 2,049 - -
2026-03-10 Mccombe William D. Chief Financial Officer 期权行权(卖出) 6,320 - -
2026-03-10 Yan Ming Chief Technology Officer 期权行权(卖出) 9,817 - -
2026-03-10 Barnett Valerie Chief Legal Officer 期权行权(卖出) 4,908 - -
2026-03-10 Jiang Wenbin President and CEO 期权行权(卖出) 15,708 - -
2026-03-10 Holder Michael Director 期权行权(卖出) 2,908 - -
2026-03-10 Chin Richard Director 期权行权 6,107 - -
2026-02-18 Yan Ming Chief Technology Officer 期权行权(卖出) 1,332 - -
2026-02-18 Barnett Valerie Chief Legal Officer 期权行权(卖出) 1,346 - -
2026-02-18 Jiang Wenbin President and CEO 期权行权(卖出) 4,514 - -
2025-11-18 Busque Philippe SVP, Global Sales and Services 期权行权(卖出) 1,536 - -
2025-11-18 Mccombe William D. Chief Financial Officer 期权行权(卖出) 13,051 - -
2025-11-18 Yan Ming Chief Technology Officer 期权行权(卖出) 1,981 - -
2025-11-18 Barnett Valerie Chief Legal Officer 期权行权(卖出) 2,016 - -
2025-06-18 Imper Vera Director 限制性股票授予 (RSU) 23,809 $3.07 $73.09K
2025-06-18 Ball Jack Director 限制性股票授予 (RSU) 23,809 $3.07 $73.09K
2025-06-18 Holder Michael Director 限制性股票授予 (RSU) 23,809 $3.07 $73.09K
2025-06-18 Chin Richard Director 限制性股票授予 (RSU) 39,062 $3.07 $119.92K
2025-06-18 Chin Richard Officer 未知 - - -
2025-06-18 Neff Deborah J Director 限制性股票授予 (RSU) 23,809 $3.07 $73.09K
2025-06-05 Imper Vera Director 期权行权(卖出) 15,706 - -
2025-06-05 Ball Jack Director 期权行权(卖出) 15,706 - -
2025-06-05 Neff Deborah J Director 期权行权(卖出) 15,706 - -
2025-06-05 Hardison Don M Director 期权行权(卖出) 15,706 - -
联系我们
🎓
SharesGrow 学院
学习如何计算内在价值,发现被低估的股票。
每周在线课程
给我们留言